Artificial Intelligence Resource, Molecular Imaging Branch, NCI, NIH, Bethesda, MD, USA.
Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
PET Clin. 2022 Jan;17(1):137-143. doi: 10.1016/j.cpet.2021.09.002.
PET imaging with targeted novel tracers has been commonly used in the clinical management of prostate cancer. The use of artificial intelligence (AI) in PET imaging is a relatively new approach and in this review article, we will review the current trends and categorize the currently available research into the quantification of tumor burden within the organ, evaluation of metastatic disease, and translational/supplemental research which aims to improve other AI research efforts.
正电子发射断层扫描(PET)成像使用靶向新型示踪剂在前列腺癌的临床管理中得到了广泛应用。人工智能(AI)在 PET 成像中的应用是一种相对较新的方法,在这篇综述文章中,我们将回顾当前的趋势,并将目前可用的研究分为以下几类:器官内肿瘤负荷的定量评估、转移性疾病的评估以及旨在改善其他 AI 研究工作的转化/补充研究。